Literature DB >> 19823985

Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England.

I Testad1, S Auer, M Mittelman, C Ballard, J Fossey, Y Donabauer, D Aarsland.   

Abstract

BACKGROUND: Understanding the underlying mechanisms and risk factors leading to agitation is crucial to reduce the severity of agitation and increase quality of life. International comparative studies offer special advantages in elucidating environmental risk factors by providing a wider diversity of environmental exposures such as nursing home structures, health care systems and genetic diversity.
METHODS: Baseline data for three different intervention studies in Austria (n = 38), England (n = 302) and Norway (n = 163) were combined posthoc. Patients were grouped according to their dementia severity using the global deterioration scale (GDS), functional assessment staging (FAST) and clinical dementia rating (CDR) scales. For the measurement of agitation, the Cohen-Mansfield Agitation Inventory (CMAI) was used. Data analysis was performed using one-way ANOVA, multivariate and linear regression analysis.
RESULTS: CMAI scores were available for 503 subjects with dementia. There were significant differences between the nursing home residents in the three countries regarding age, gender and dementia severity (all p values < 0.001). In the multivariate analyses, the level of agitation differed with higher mean scores in the Austrian (mean (SD) score 51.9(21.8)) compared to UK (43.3(16.1)) and Norwegian (41.6(13.2)) nursing homes (p = 0.002). Similarly, the use of psychotropic drugs differed significantly, with a higher proportion of neuroleptics in UK (48%, p < 0.001) and Austrian (52.6%; p = 0.001) compared to Norwegian (19%) nursing homes.
CONCLUSION: We found differences in agitation and antipsychotic drug use which are likely related to structural and cultural differences in nursing homes in three European countries. These findings suggest that structural changes can improve quality of care and quality of life for nursing home residents. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19823985     DOI: 10.1002/gps.2414

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  Sedative load among long-term care facility residents with and without dementia: a cross-sectional study.

Authors:  J Simon Bell; Heidi T Taipale; Helena Soini; Kaisu H Pitkälä
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 2.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

3.  Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT.

Authors:  Claire A Surr; Ivana Holloway; Rebecca Ea Walwyn; Alys W Griffiths; David Meads; Rachael Kelley; Adam Martin; Vicki McLellan; Clive Ballard; Jane Fossey; Natasha Burnley; Lynn Chenoweth; Byron Creese; Murna Downs; Lucy Garrod; Elizabeth H Graham; Amanda Lilley-Kelley; Joanne McDermid; Holly Millard; Devon Perfect; Louise Robinson; Olivia Robinson; Emily Shoesmith; Najma Siddiqi; Graham Stokes; Daphne Wallace; Amanda J Farrin
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

4.  Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats.

Authors:  Kai Lei; Guo-Fang He; Cheng-Liang Zhang; Ya-Nan Liu; Juan Li; Guang-Zhao He; Xi-Ping Li; Xiu-Hua Ren; Dong Liu
Journal:  Exp Anim       Date:  2017-12-08

5.  Cross-sectional study of prevalence of dementia, behavioural symptoms, mobility, pain and other health parameters in nursing homes in Austria and the Czech Republic: results from the DEMDATA project.

Authors:  Stefanie R Auer; Margit Höfler; Elisabeth Linsmayer; Anna Beránková; Doris Prieschl; Paulina Ratajczak; Michal Šteffl; Iva Holmerová
Journal:  BMC Geriatr       Date:  2018-08-13       Impact factor: 3.921

6.  A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use.

Authors:  T Joseph Mattingly
Journal:  Neurol Ther       Date:  2015-09-02

7.  PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol.

Authors:  Klaas van der Spek; Debby L Gerritsen; Martin Smalbrugge; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Claudia H W Smeets; Sytse U Zuidema; Raymond T C M Koopmans
Journal:  BMC Psychiatry       Date:  2013-11-15       Impact factor: 3.630

8.  Medication monitoring for people with dementia in care homes: the feasibility and clinical impact of nurse-led monitoring.

Authors:  Sue Jordan; Marie Gabe; Louise Newson; Sherrill Snelgrove; Gerwyn Panes; Aldo Picek; Ian T Russell; Michael Dennis
Journal:  ScientificWorldJournal       Date:  2014-02-23

9.  Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial.

Authors:  Claire A Surr; Rebecca E A Walwyn; Amanda Lilley-Kelly; Robert Cicero; David Meads; Clive Ballard; Kayleigh Burton; Lynn Chenoweth; Anne Corbett; Byron Creese; Murna Downs; Amanda J Farrin; Jane Fossey; Lucy Garrod; Elizabeth H Graham; Alys Griffiths; Ivana Holloway; Sharon Jones; Baber Malik; Najma Siddiqi; Louise Robinson; Graham Stokes; Daphne Wallace
Journal:  Trials       Date:  2016-06-24       Impact factor: 2.279

10.  Long-term effects of a 12 weeks high-intensity functional exercise program on physical function and mental health in nursing home residents with dementia: a single blinded randomized controlled trial.

Authors:  Elisabeth Wiken Telenius; Knut Engedal; Astrid Bergland
Journal:  BMC Geriatr       Date:  2015-12-03       Impact factor: 3.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.